English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Dec 3, 2025

Patients Come First spokesperson: ‘Congress must recognize the urgent need to reform the 340B Program'

Patient Daily | Dec 3, 2025

Capricor reports positive phase III results for DMD cardiomyopathy therapy after initial FDA rejection

Patient Daily | Dec 3, 2025

FDA proposes reducing primate use in antibody therapy testing

Patient Daily | Dec 3, 2025

New UK/EU regulations and AI adoption shape priorities for contract research organizations

Patient Daily | Dec 3, 2025

ENT & Allergy Associates partners with Houston group for first Texas expansion

Patient Daily | Dec 3, 2025

American Lung Association opposes proposed weakening of federal vehicle fuel economy rules

Patient Daily | Dec 2, 2025

American Lung Association calls for widespread flu vaccination after severe 2024–25 season

Patient Daily | Dec 2, 2025

Experts question FDA official's claims linking child deaths to COVID-19 vaccines

Trending

+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'

+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal

+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'

+ Pharmaceuticals
Patient Daily | Mar 17, 2026

Biogen, Sarepta, and Edgewise present new data at Muscular Dystrophy Association 2026 conference

  • « First
  • «
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily